Open Access<p>Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study</p>
Author(s) -
Linbin Lu,
Yan Zhang,
Peichan Zheng,
Zhen Wu,
Xuewen Wang,
Yaying Chen,
Xiong Chen
Publication year - 2020
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s274349
Subject(s) - medicine , hepatocellular carcinoma , hazard ratio , proportional hazards model , confounding , gastroenterology , confidence interval , platelet , oncology , cohort
Platelet count (PLT) has been proved as an essential biomarker for the survival of hepatocellular carcinoma (HCC). However, the prognostic value of PLT change (ΔPLT) is still uncertain. The aim of this study was to explore the relationship between ΔPLT and HCC survival after transarterial chemoembolization (TACE) treatment.